Casting Boom Can't Hide the Margin Trap

Kirloskar's Q1 is a split-screen quarter: casting sales jumped 18% in volume, pig iron prices recovered ₹3.4k per tonne, and capacity at Rajpura is fully booked. Yet reported net profit fell 13.4% year-on-year, and operating margins came in at 10.5%, well below the 12.5% baseline and far short of the 15% medium-term target. The culprit is ₹58 crore in power and fuel cost inflation—mostly LPG surges in Solapur and coal price swings during the peak June–August window—that is only partially flowing through to customers. This is the core tension: volume momentum is real, but margin expansion remains unproven.

Of the ₹58 crore in other-expense inflation, ₹28–29 crore came from rate increases (LPG costs doubled in Solapur; regulatory charges on green power tightened). Another ₹28–29 crore came from volume—higher casting production pushes absolute fuel spend up. Pig iron external sales fell 3% year-on-year (despite higher per-tonne realization), and steel and tube segments absorbed cost pressure. Overall EBITDA margin compressed to 12–13% from the 12.5% prior range. Management is confident on price pass-through—castings are in customer negotiation now, steel price hikes have been announced—but the timing and quantum of realization improvement are still vague. This is the battle the company must win in Q2 and Q3 to restore the margin recovery narrative.

Management stated that 'casting realization held year-on-year' despite the commodity cycle. Yet overall OPM fell from 12.5% to 10.5%, suggesting margin compression even as casting volume grew 18%. The claim is unverified—casting margin is not separately disclosed—and contradicted by the aggregate P&L. On pig iron, the recovery story is solid: prices rose ₹3.4k per tonne quarter-on-quarter, from ₹39k to ₹42.4k/MT, a real move. But realization gain was only 'slight,' eaten by coal and currency cost inflation. On FY27 guidance, management reaffirmed 15%+ overall volumetric growth (castings +17–20%, steel +20%, tubes +10%), which is achievable if all units hit targets, but it hinges on flawless execution. Tubes remain the weak link: sales fell 14% year-on-year, O&G demand is subdued, and China dumping persists. To hit 15% full-year revenue growth, Kirloskar needs 16%+ growth in Q2–Q4—a steep ramp from Q1's 4.3%.

Casting guidance shifted subtly but meaningfully. Prior FY27 guidance pointed to 185k–190k tonnes; management now guides 162k (Q1 delivered) ramping to 188k (17–18% growth). Rajpura Phase 1 expansion is accelerating, and the Solapur 2-part foundry (15k MT) is targeted for October commissioning. This implies 270k MT realizable capacity within the year. However, the margin recovery timeline moved: no longer 'imminent' but now explicitly 'Q2–Q3' once price hikes pass through. Green power ROI was also revised down—regulatory restrictions on power trading and usage (8-hour cap instead of 17 hours) reduce annual benefit to ₹80 crore and extend payback from 3 to 3.6 years, a material shift. Tube capex was extended: the expander mill for 350k MT capacity will take 2 years to build and 3–4 years to reach full utilization, not the 2–3 years previously estimated.

The market's reaction has been unambiguous. The result announcement on 05 Aug triggered a 2.86% decline on day-1, which widened to –4.4% by day-5 and has not faded since. That persistence is the street's verdict—skepticism on the near-term margin recovery narrative. Stock technicals are deeply oversold (RSI 14.1), trading –18.6% off its all-time high and below all three key moving averages (SMA20, SMA50, SMA200), which typically signals capitulation or deep opportunity. Volume is declining, suggesting weak conviction at current levels. On ownership, FII trimmed 0.1 percentage point (1.78% → 1.68%), DII is flat at 12.56%, and promoter is steady at 50.78%—no dramatic flows, but the FII trim suggests cautious sentiment. The combination of oversold technicals, weak institutional flows, and a held –4.4% sell-off suggests the market is waiting for Q2 EBITDA margin clarity before re-engaging on the upside. The stock is repriced lower, but only if management delivers on the margin recovery thesis does the downdraft look like opportunity rather than validation of weakness.